Bætt framboð bóluefna fyrir fullorðna
Safety Classified by Officially
Á undanförnum vikum hafa tvö bóluefni verið markaðssett á Íslandi ætluð fullorðnum í áhættuhópum, vegna ristils annars vegar og pneumókokkasýkinga hins vegar.
Því hafa í fyrsta sinn verið birtar leiðbeiningar um notkun ristilbóluefnis á Íslandi, og uppfærðar leiðbeiningar um notkun pneumókokkabóluefna.
This is an extract. The publication continues at the source.
Source: Embætti landlæknis (Directorate of Health).
Read the original at the source: https://island.is/s/landlaeknir/frett/baett-frambod-boluefna-fyrir-fullordna
Officially imported this from Embætti landlæknis (Directorate of Health)’s own source and shows an extract. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.
Provenance
- Organization
- Embætti landlæknis (Directorate of Health) — imported from official source
- Official source
- https://island.is/rss.xml?organization=landlaeknir RSS
- Imported
- October 03, 2026 20:38
- Versions
- 1 recorded
- Identity
-
https://island.is/s/landlaeknir/frett/baett-frambod-boluefna-fyrir-fullordna